JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

Strona główna・Stock List・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Closed

SectorHealthcare

495.43 -0.65

Buy Sell

Overview

Share price change

24h

Current

Min

491.12

Max

501.64

Key metrics
By Trading Economics
Income	-72M -114M
Sales	74M 287M
Profit margin	-39.75
Employees	528
EBITDA	-68M -106M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+38.05% upside

Dividends
By Dow Jones
Next Earnings	25 lut 2026

Market Stats
By TradingEconomics
Market Cap	2.1B 11B
Previous open	496.08
Previous close	495.43

News Sentiment

By Acuity

28%

72%

59 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

263.2 / 277.1 Support & Resistance

Madrigal Pharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 sty 2026, 23:51 UTC

Earnings

Correction to Samsung Fourth-Quarter Net Profit Article

28 sty 2026, 23:49 UTC

Hot Stocks

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28 sty 2026, 23:19 UTC

Earnings

Samsung's Fourth-Quarter Net Profit Beats Consensus

28 sty 2026, 22:43 UTC

Earnings

Waste Management Logs Higher 4Q Profit as Revenue Rises

29 sty 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

29 sty 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

29 sty 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

29 sty 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

28 sty 2026, 23:49 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28 sty 2026, 23:30 UTC

Market Talk

Tesla to Use Car Factory for Robot Aims -- Market Talk

28 sty 2026, 23:28 UTC

Earnings

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28 sty 2026, 23:26 UTC

Earnings

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28 sty 2026, 23:21 UTC

Earnings

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 sty 2026, 23:18 UTC

Earnings

Acquisitions, Mergers, Takeovers

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 sty 2026, 22:58 UTC

Earnings

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28 sty 2026, 22:48 UTC

Market Talk

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28 sty 2026, 22:45 UTC

Earnings

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28 sty 2026, 22:44 UTC

Earnings

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28 sty 2026, 22:43 UTC

Earnings

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28 sty 2026, 22:41 UTC

Earnings

Hot Stocks

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28 sty 2026, 22:41 UTC

Market Talk

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28 sty 2026, 22:41 UTC

Earnings

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28 sty 2026, 22:40 UTC

Earnings

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28 sty 2026, 22:39 UTC

Earnings

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28 sty 2026, 22:38 UTC

Earnings

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28 sty 2026, 22:37 UTC

Earnings

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28 sty 2026, 22:35 UTC

Earnings

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28 sty 2026, 22:26 UTC

Market Talk

Earnings

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28 sty 2026, 22:20 UTC

Market Talk

Global Equities Roundup: Market Talk

28 sty 2026, 22:20 UTC

Market Talk

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Peer Comparison

Price change

Madrigal Pharmaceuticals Inc Forecast

Price Target

By TipRanks

38.05% upside

12 Months Forecast

Average 690.8 USD 38.05%

High 964 USD

Low 533 USD

Based on 13 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

Buy

Hold

Sell

Based on 13 analysts giving stock ratings to Madrigal Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

263.2 / 277.1Support & Resistance

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Sentiment

By Acuity

59 / 352 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.